| Entry |
|
|---|
| Name |
Vigabatrin (JAN/USAN/INN);
Sabril (TN)
|
|---|
| Product |
|
|---|
| Formula |
C6H11NO2
|
|---|
| Exact mass |
129.079
|
|---|
| Mol weight |
129.157
|
|---|
| Structure |
     |
|---|
| Activity |
Anticonvulsant [tardive dyskinesia]
|
|---|
| Remark |
|
|---|
| Target |
GABA transaminase inhibitor [HSA: 18] [KO: K13524] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG04 Vigabatrin
D00535 Vigabatrin (JAN/USAN/INN)
USP drug classification [BR:br08302]
Anticonvulsants
Gamma-aminobutyric Acid (GABA) Augmenting Agents
Vigabatrin
D00535 Vigabatrin (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases
GABA transaminase [HSA:18] [KO:K13524]
Vigabatrin [ATC:N03AG04]
D00535 Vigabatrin (JAN/USAN/INN)
 |
|---|
| Other DBs |
CAS: 60643-86-9 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 9
1 C1c C 23.6410 -19.0753
2 C1b C 24.8557 -18.3746
3 C2b C 22.4264 -18.3805
4 N1a N 23.6469 -20.4768
5 C1b C 26.0703 -19.0636
6 C2a C 21.2119 -19.0812
7 C6a C 27.2850 -18.3688
8 O6a O 28.4938 -19.0579
9 O6a O 27.2791 -16.9614
BOND 8
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 5 7 1
7 7 8 1
8 7 9 2
|
|---|
